Laura Eadie


  • 230 Citations
  • 7 h-Index
If you made any changes in Pure these will be visible here soon.

Personal profile

Public Profile

Acute Lymphoblastic Leukaemia (ALL) is an extremely heterogeneous disease with subtypes of patients exhibiting a diverse range of genetic mutations. Certain subtypes of ALL can be treated with drugs already in clinical use. Laura undertook her Fulbright fellowship (2016-2017) at St. Jude Children’s Research Hospital in Memphis, Tennessee where she learned mouse models of high-risk ALL. She also investigated the functional significance of mutations to the transcription factor MYB, which have recently been identified in T-ALL patients. Future work will expand on this utilizing xenograft and transgenic mouse models, with particular focus on T-ALL. This project aims to 1) model mechanisms of drug resistance and 2) develop models for newly discovered mutations in order to aid the development of novel targeted and/or combination therapeutic approaches. Ultimately, results will inform clinical practice, impacting significantly on response to therapy and overall survival of adults and children with high-risk ALL. 

Education / Academic qualification

PhD, University of Adelaide

30 Mar 200927 Mar 2013

Bachelor's Degree (Honours), University of Adelaide

17 Jan 20062 Dec 2006

Bachelor's Degree, University of Adelaide

22 Jan 20032 Dec 2005

External positions

Post Doctoral Research Associate, St. Jude Children's Research Hospital

14 Aug 201615 Aug 2017

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2018

  • 230 Citations
  • 7 h-Index
  • 7 Article
  • 3 Letter
  • 1 Review article
18 Citations


Australian Postgraduate Award

Laura Eadie (Recipient), 2008

Prize: Other distinction

Baillieu Supplementary Research Scholarship

Laura Eadie (Recipient), 2008

Prize: Other distinction

Biomedical Postgraduate Scholarship

Laura Eadie (Recipient), 2008

Prize: Other distinction

Activities 2016 2016

  • 2 Invited talk